Skimping on drug benefits may end up costing more than the savings:

A new study done by the nonprofit Integrated Benefits Institute, on several thousand workers diagnosed with rheumatoid arthritis, shows that employers who passed on most of the cost of drugs to their employees, could end up losing more than they save, through absenteeism and lost productivity. Michael Chernew, a health policy economist at Harvard Medical School who was not involved in the arthritis study, said: “The basic message is very consistent with all the work we have done: co-pays go up, people use their medications less, and bad things happen.”

Sphere It


|



Comments

Name (required)

Email (required)

Website

Leave a comment